About Recordati

Recordati is a global pharmaceutical company listed on the Italian stock exchange, operating in 150 countries with over 4,500 employees. The company develops and commercialises medicines for people with common and rare diseases. With integrated operations spanning research, manufacturing and commercialisation, Recordati provides treatment options across specialty care, primary care, consumer healthcare and rare diseases. Founded in the 1920s in Italy, Recordati has grown over 100 years into an international pharmaceutical force. The company discovers products that improve quality of life and provides widespread access to treatments, committing to sustainable growth while serving patients and communities worldwide.